Literature DB >> 29892474

Ablation for Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction.

Jackson J Liang1, David J Callans1.   

Abstract

AF and heart failure with reduced ejection fraction (HFrEF) frequently coexist. Catheter ablation is an increasingly utilised treatment strategy for patients with AF and can be safely performed and is effective in achieving sinus rhythm for patients with HFrEF. Successful ablation may result in improved LV function, clinical heart failure status, quality of life and possibly even mortality. This review summarises the literature analysing efficacy, safety and outcomes of AF ablation for patients with HFrEF.

Entities:  

Keywords:  Atrial fibrillation; cardiomyopathy; catheter ablation; heart failure; outcomes

Year:  2018        PMID： 29892474      PMCID： PMC5971677          DOI： 10.15420/cfr.2018:3:1

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN： 2057-7540


  58 in total

1.  Is heart rate important for patients with heart failure in atrial fibrillation?

Authors:  Damien Cullington; Kevin M Goode; Jufen Zhang; John G F Cleland; Andrew L Clark
Journal:  JACC Heart Fail       Date:  2014-04-30       Impact factor: 12.035

2.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  J Am Coll Cardiol       Date:  2017-04-28       Impact factor: 24.094

3.  Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function.

Authors:  Claudio Tondo; Massimo Mantica; Giovanni Russo; Andrea Avella; Lucia De Luca; Augusto Pappalardo; Rafael Lopes Fagundes; Edo Picchio; Francesco Laurenzi; Vito Piazza; Irma Bisceglia
Journal:  Pacing Clin Electrophysiol       Date:  2006-09       Impact factor: 1.976

4.  Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction.

Authors:  T Jared Bunch; Heidi T May; Tami L Bair; Victoria Jacobs; Brian G Crandall; Michael Cutler; J Peter Weiss; Charles Mallender; Jeffrey S Osborn; Jeffrey L Anderson; John D Day
Journal:  J Cardiovasc Electrophysiol       Date:  2015-02-11

5.  Six-Year Clinical Outcomes After Catheter Ablation of Atrial Fibrillation in Patients With Impaired Left Ventricular Function.

Authors:  Andreas Rillig; Hisaki Makimoto; Jascha Wegner; Tina Lin; Christian Heeger; Christine Lemes; Thomas Fink; Andreas Metzner; Erik Wissner; Shibu Mathew; Peter Wohlmuth; Karl-Heinz Kuck; Roland Richard Tilz; Feifan Ouyang
Journal:  J Cardiovasc Electrophysiol       Date:  2015-09-03

6.  Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.

Authors:  Waqas Ullah; Liang-Han Ling; Sandeep Prabhu; Geoffrey Lee; Peter Kistler; Malcolm C Finlay; Mark J Earley; Simon Sporton; Yaver Bashir; Tim R Betts; Kim Rajappan; Glyn Thomas; Edward Duncan; Andrew Staniforth; Ian Mann; Anthony Chow; Pier Lambiase; Richard J Schilling; Ross J Hunter
Journal:  Europace       Date:  2016-02-03       Impact factor: 5.214

7.  Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control.

Authors:  Sotirios Nedios; Philipp Sommer; Nikolaos Dagres; Jedrzej Kosiuk; Arash Arya; Sergio Richter; Thomas Gaspar; Nikolaos Kanagkinis; Borislav Dinov; Christopher Piorkowski; Andreas Bollmann; Gerhard Hindricks; Sascha Rolf
Journal:  Heart Rhythm       Date:  2013-12-27       Impact factor: 6.343

8.  Atrial fibrillation ablation in systolic dysfunction: clinical and echocardiographic outcomes.

Authors:  Tasso Julio Lobo; Carlos Thiene Pachon; Jose Carlos Pachon; Enrique Indalecio Pachon; Maria Zelia Pachon; Juan Carlos Pachon; Tomas Guillermo Santillana; Juan Carlos Zerpa; Remy Nelson Albornoz; Adib Domingos Jatene
Journal:  Arq Bras Cardiol       Date:  2014-11-11       Impact factor: 2.000

9.  Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation.

Authors:  Tom De Potter; Antonio Berruezo; Lluis Mont; Maria Matiello; David Tamborero; Claudio Santibañez; Begoña Benito; Nibaldo Zamorano; Josep Brugada
Journal:  Europace       Date:  2010-01       Impact factor: 5.214

Review 10.  Pathophysiology, diagnosis and treatment of tachycardiomyopathy.

Authors:  Claire A Martin; Pier D Lambiase
Journal:  Heart       Date:  2017-08-30       Impact factor: 5.994
View more
  6 in total

1.  Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.

Authors:  Mai Azuma; Shingo Kato; Ryusuke Sekii; Sho Kodama; Kei Kinoshita; Keisuke Suzurikawa; Minako Kagimoto; Naoki Nakayama; Kohei Iguchi; Kazuki Fukui; Tae Iwasawa; Daisuke Utsunomiya; Kazuo Kimura; Kouichi Tamura
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-16       Impact factor: 2.357

Review 2.  Catheter ablation of atrial fibrillation-A key role in heart failure therapy?

Authors:  Beatriz Tose Costa Paiva; Thomas H Fischer; Johannes Brachmann; Sonia Busch
Journal:  Clin Cardiol       Date:  2019-02-12       Impact factor: 2.882

3.  Concomitant Atrial Fibrillation Procedures During Cardiac Surgery in a UK Center: Reflection of Worldwide Practice?

Authors:  Alina-Adriana Mistirian; Martin T Yates; Wael I Awad
Journal:  Front Cardiovasc Med       Date:  2022-03-10

4.  P-Wave Beat-to-Beat Analysis to Predict Atrial Fibrillation Recurrence after Catheter Ablation.

Authors:  Dimitrios Tachmatzidis; Anastasios Tsarouchas; Dimitrios Mouselimis; Dimitrios Filos; Antonios P Antoniadis; Dimitrios N Lysitsas; Nikolaos Mezilis; Antigoni Sakellaropoulou; Georgios Giannopoulos; Constantinos Bakogiannis; Konstantinos Triantafyllou; Nikolaos Fragakis; Konstantinos P Letsas; Dimitrios Asvestas; Michael Efremidis; Charalampos Lazaridis; Ioanna Chouvarda; Vassilios P Vassilikos
Journal:  Diagnostics (Basel)       Date:  2022-03-28

5.  Ablation Therapy for Persistent Atrial Fibrillation.

Authors:  Ikechukwu Ifedili; Kristina Mouksian; David Jones; Ibrahim El Masri; Mark Heckle; John Jefferies; Yehoshua C Levine
Journal:  Curr Cardiol Rev       Date:  2022

6.  Impact of Atrial Tachyarrhythmia Recurrence on the Development of Long-Term Adverse Clinical Events Following Catheter Ablation in Patients With Atrial Fibrillation With Systolic Impairment: A Single-Center Observational Study.

Authors:  Hironori Ishiguchi; Yasuhiro Yoshiga; Akihiko Shimizu; Takeshi Ueyama; Makoto Ono; Masakazu Fukuda; Takayoshi Kato; Shohei Fujii; Masahiro Hisaoka; Tomoyuki Uchida; Takuya Omuro; Mototsugu Shimokawa; Takayuki Okamura; Shigeki Kobayashi; Masafumi Yano
Journal:  J Am Heart Assoc       Date:  2022-02-03       Impact factor: 6.106
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.